I.M. MELNIKOVA¹, Yu.L. MIZERNITSKIY²

¹Yaroslavl State Medical Academy, 5 Revolyutzionnaya Str., 150000 Yaroslavl, Russian Federation

²Institute of Pediatrics of Russian National Research Medical University named after N.I. Pirogov, 2 Taldomskaya St., Moscow, Russian Federation, 125412

Melnikova I.M. — D. Med. Sc., Professor, Head of the Department of Hospital Pediatrics, tel. (4852) 72-91-18, e-mail: imyar@mail.ru

Mizernitskiy Yu.L. — D. Med. Sc., Professor, Head of the Department of Pulmonology, tel. +7-916-1453282, e-mail: yulmiz@mail.ru

The article presented adetailed review of data onmucociliary clearance and tracheobronchitalsecretion in norm and lungs pathology in children. Modern methods of expectorative and mucolytic therapy are given. Practical references on its rational application at acute and chronic bronchopulmonarypathology in children of various ages are provided.

Key words: children, expectorative and mucolytic therapy.

 

 

REFERENCES

1. Amelina E.L., Anaev E.Kh., Krasovskiy S.A. et al. Mukoaktivnaya terapiya, pod red. A.G. Chuchalina, A.S. Belevskogo [Mucoactive therapy. Edit. by A.G. Chuchalina, A.S. Belevsky]. Moscow: ID “Atmosfera”, 2006. 127 p.

2. Batozhargalova B.Ts., Mizernitskiy Yu.L. Effect of exposure to tobacco smoke on the respiratory health of adolescents. Vestnik NGU (ser.: Biologiya, klin. meditsina), 2012, no. 10 (3), pp. 198-206 (in Russ.).

3. Bogdanova A.V. Effectiveness of the drug in the treatment of recurrent Fluifort and chronic bronchitis in children. Pul’monologiya detskogo vozrasta: problemy i resheniya. Iss.5, 2005. Pp. 77-79 (in Russ.).

4. Vasil’eva O.S., Gushchina E.E. Ascoril in the treatment of diseases of the respiratory system: new about the famous. RMZh, 2012, no. 26 (in Russ.), available at: http://rmj.ru/articles_8448.htm (accessed: 29.07. 2013).

5. Volkov I.K., Davydova I.V., Kulichikhin V.G., Lukina O.F. New features mucolytic therapy for chronic and recurrent lung diseases in children. Consilium Medicum. Pul’monologiya, 2006, 8 (1) (in Russ.), available at: http://www.consilium-medicum.com/pylmo/article/9559/ (accessed: 21.11.2010).

6. Mizernitskiy Yu.L., Sorokina E.V. Printsipy terapii ostrykh respiratornykh zabolevaniy (ORVI, bronkhitov i pnevmoniy) [Principles of therapy of acute respiratory infections (ARI, bronchitis and pneumonia)]. Rebenok i lekarstvo (2-e izd.). Vol. 2. Farmakoterapiya v pediatrii. Moscow, Overley, 2008. Pp. 479-500.

7. Nauchno-prakticheskaya programma Soyuza pediatrov Rossii “Ostrye respiratornye zabolevaniya u detey: lechenie i profilaktika” [Scientific and practical program of the Union of pediatricians of Russia «Acute respiratory infections in children: treatment and prevention]. Moscow, 2002. 73 p.

8. Khodzitskaya V.K., Khodzitskaya S.V. Violation and correction of mucociliary clearance of respiratory diseases, and otolaryngology. Bolezni i antibiotiki, 2010, no. 1 (in Russ.), available at: http://antibiotic.mif-ua.com/archive/issue-14554/article-14576/ (data obrashcheniya 20.04.2012).

9. Nadel J.A. Mucous hypersecretion and relationship to cough. Pulm Pharmacol Ther., 2013, Feb 19, available at: http://www.ncbi.nlm.nih.gov/pubmed/23434445 (accessed: 20.07 2013).

10. Respiratornaya meditsina: rukovodstvo, pod red. A.G. Chuchalina: v 2 t. [Respiratory Medicine: manual. Ed. by A.G. Chuchalin: in 2 vol.]. Moscow: GEOTAR-Media, 2007. Vol. 1. 797 p.

11. Seagrave J., Albrecht H.H., Hill D.B. et al. Effects of guaifenesin, N-acetylcysteine, and ambroxol on MUC5AC and mucociliary transport in primary differentiated human tracheal-bronchial cells. Respir Res., 2012, Oct 31, vol. 13. P. 98.

12. Mizernitskiy Yu.L. Otkharkivayushchie i mukoliticheskie sredstva v terapii bronkholegochnykh zabolevaniy u detey [Expectorants and mucolytics in the treatment of bronchopulmonary diseases in children]. Rukovodstvo po farmakoterapii v pediatrii i detskoy khirurgii. Vol.1. Farmakoterapiya v pediatricheskoy pul’monologii. Moscow: Medpraktika-M, 2002. Pp. 123-140.

13. Chuchalin A.G., Abrosimov V.N. Kashel’. Izd. 2-e, pererab. i dop. [Cough. Ed. 2nd, Revised. and add.]. Moscow: Chelovek i lekarstvo, 2012. 127 p.

14. Kapranov N.I., Kashirskaya N.Yu. Mukovistsidoz [Cystic fibrosis]. Khronicheskie zabolevaniya legkikh u detey. Moscow: Praktika, 2011. Pp. 94-107.

15. Mizernitskiy Yu.L., Mel’nikova I.M. Mukoliticheskaya i otkharkivayushchaya farmakoterapiya pri zabolevaniyakh legkikh u detey [Mucolytic and expectorant drug therapy for lung disease in children]. Moscow: Medpraktika-M, 2013. 120 p.

16. Geppe N.A., Snegotskaya M.N., Nikitenko A.A. Acetylcysteine in the treatment of cough in children. Consilium Medicum. Pediatriya, 2007, no. 2, pp. 35-40 (in Russ.).

17. Duijvestijn Y.C., Mourdi N., Smucny J. et al. Acetylcysteine and carbocysteine for acute upper and lower respiratory tract infections in pediatric patients without chronic broncho-pulmonary disease. Cochrane Database Syst Rev., 2009, Jan 21, vol. (1). CD003124.

18. Millea P.J. N-acetylcysteine: multiple clinical applications. Am Fam Physician, 2009, Aug 1, vol. 80 (3), pp. 265-269.

19. Varelogianni G., Oliynyk I., Roomans G.M., Johannesson M. The effect of N-acetylcysteine on chloride efflux from airway epithelial cells. Cell Biol Int., 2010, Jan 27, vol. 34 (3), pp. 245-252.

20. Zhao T., Liu Y. N-acetylcysteine inhibit biofilms produced by Pseudomonas aeruginosa. BMC Microbiol., 2010, May 12, vol. 10 (1), p. 140.

21. Beeh K.M., Beier J., Esperester A., Paul L.D. Antiinflammatory properties of ambroxol. Eur J Med Res., 2008, Dec 3, vol. 13 (12), pp. 557-562.

22. Yang B., Yao D.F., Ohuchi M. et al. Ambroxol suppresses influenza-virus proliferation in the mouse airway by increasing antiviral factor levels. EurRespir J., 2002, vol. 19, pp. 952-958.

23. Ishiura Y., Fujimura M., Yamamori C. et al. Effect of carbocysteine on cough reflex to capsaicin in asthmatic patients. Br J ClinPharmacol., 2003; Jun., vol. 55 (6), pp. 504-510.

24. Macciò A., Madeddu C., Panzone F., Mantovani G. Carbocysteine: clinical experience and new perspectives in the treatment of chronic inflammatory diseases. Expert OpinPharmacother., 2009, Mar., vol. 10 (4), pp.693-703.

25. Garavaglia M.L., Bononi E., Dossena S. et al. S-CMC-Lys protective effects on human respiratory cells during oxidative stress. Cell PhysiolBiochem., 2008; 22(5-6). Pp. 455-464.

26. Nogawa H., Ishibashi Y., Ogawa A. et al. Carbocysteine can scavenge reactive oxygen species in vitro. Respirology, 2009; Jan 14(1). Pp. 53-59.

27. Ndour C., Ahmed K., Nakagawa T. et al. Modulating effects of mucoregulating drugs on the attachment of Haemophilusinfluenzae. Microb. Pathog., 2001, 30 (3). Pp. 121-127.

28. Yasuda H., Yamaya M., Sasaki T. et al. Carbocisteine inhibits rhinovirus infection in human tracheal epithelial cells. Eur. Respir. J., 2006; 28 (1). Pp. 51-58.

29. Loginevskaya Ya.V. Klinicheskaya effektivnost’ differentsirovannoy mukoaktivnoy terapii u detey s zabolevaniyami organov dykhaniya: avtoref. dis. … kand. med. nauk [Clinical efficacy of differentiated mucoactive therapy in children with respiratory diseases. Synopsis of dis. PhD med. sci.]. Voronezh, 2013. 24 p.

30. Mel’nikova I.M., Mizernitskiy Yu.L., Batozhargalova B.Ts., Loginevskaya Ya.V. Modern principles of mucolytic therapy in children with acute and chronic bronchopulmonary diseases. Rossiyskiy vestnik perinatologii i pediatrii, 2011, vol. 56, no. 2, pp. 45-50 (in Russ.).

31. Tatochenko V.K., Volkov I.K., Rachinskiy S.V. Kriterii diagnostiki i printsipy lecheniya retsidiviruyushchikh i khronicheskikh zabolevaniy legkikh u detey. Posobie dlya vrachey [Diagnostic criteria and treatment guidelines recurrent and chronic lung disease in children. Manual for physicians]. Moscow, MZ RF i NTsZD RAMN, 2001. 23 p.

32. Mizernitskiy Yu.L., Mel’nikova I.M., Loginevskaya Ya.V., Batozhargalova B.Ts., Kozlova L.A. Clinical efficacy of combined mucoactive expectorant therapy in children with acute respiratory infections of the lower respiratory tract. Lechashchiy vrach, 2011, no. 11, pp. 107-112 (in Russ.).

33. Mizernitskiy Yu.L., Mel’nikova I.M., Batozhargalova B.Ts., Loginevskaya Ya.V. Modern mucoactive therapy in children with acute and chronic bronchopulmonary diseases. RMZh. Mat’ i ditya. Pediatriya, 2011, vol. 19, no. 3, pp. 150-155 (in Russ.).

34. Kolosov V.P., Dobrykh V.A., Odireev A.N., Lutsenko M.T. Dispergatsionnyy i mukotsiliarnyy transport pri boleznyakh organov dykhaniya [Air dispersion and mucociliary transport in diseases of the respiratory system]. Vladivostok: Dal’nauka, 2011. 276 p.